Epstein-Barr virus in Hodgkin's disease

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Epstein-Barr virus (EBV) is a widespread herpesvirus causing asymptomatic lifelong infections.
• EBV is associated with several B-cell malignancies, including Hodgkin's disease (HD).
• Recent findings suggest shared pathogenesis among EBV-associated lymphomas.

Purpose of the Study:

• To review the biology and T-cell control of EBV infection.
• To examine the links between EBV and endemic Burkitt's lymphoma, post-transplant lymphoproliferative disease, and HD.
• To discuss the potential for EBV-specific T-cell immunotherapy in EBV-positive HD.

Main Methods:

• Literature review of EBV biology, infection control, and associated malignancies.
• Analysis of evidence linking EBV to B-cell lymphomas.
• Discussion of current progress and future prospects for immunotherapy.

Main Results:

• EBV establishes persistent infections controlled by cytotoxic T lymphocytes.
• EBV is implicated in the pathogenesis of multiple B-cell lymphomas.
• Viral antigen expression in EBV-positive HD suggests immunotherapy potential.

Conclusions:

• EBV infection and its control by T-cells are crucial areas of study.
• The shared B-cell origin of EBV-associated lymphomas warrants further investigation.
• EBV-specific T-cell immunotherapy holds promise for treating EBV-positive HD.